ORCL Stock Analysis: Oracle | NYSE
Software - Infrastructure | NYSE, USA | Market Cap: 411.344m USD | 12M Return: -52.9% | US68389X1054 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.00B
EPS Trend: 95.7%
Qual. Beats: 2
Rev. Trend: 96.5%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Oracle Corporation (NYSE: ORCL) is a global provider of enterprise IT products and services, headquartered in Austin, Texas, and founded in 1977. The company operates across cloud applications, infrastructure, and hardware, serving businesses, government agencies, and educational institutions both directly and through indirect channels. Its cloud applications portfolio includes Oracle Fusion suites for ERP, EPM, SCM, and HCM, along with NetSuite, Oracle Health, and sales/service/marketing solutions. Oracle also sells cloud and on-premise licenses, support services, and industry-specific cloud solutions.
In infrastructure, Oracle offers the Oracle and MySQL Databases, Java, middleware, cloud-based compute, storage, and networking capabilities, and technologies such as its autonomous database, AI, IoT, machine learning, digital assistant, and blockchain. The hardware segment includes Oracle engineered systems, enterprise servers, storage solutions, virtualization software, operating systems, and related support and consulting services. Oracle maintains a strategic alliance with Metron, Inc.
Operating within the GICS Information Technology sector and Systems Software sub-industry, Oracle is a mega-cap company listed since 1986. Its business model spans software, cloud services, and hardware, making it a full-stack enterprise technology provider competing with peers like SAP, Microsoft, and IBM.
- Cloud infrastructure revenue accelerates as enterprise migrations scale
- Cerner Health segment faces slow margin recovery and integration drag
- Capital returns slow as Oracle prioritizes AI capex and debt paydown
| Net Income: 18.9b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -6.21 > 1.0 |
| NWC/Revenue: 11.31% < 20% (prev -25.82%; Δ 37.13% < -1%) |
| CFO/TA 0.15 > 3% & CFO 46.9b > Net Income 18.9b |
| Net Debt (149b) to EBITDA (37.7b): 3.96 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.00b) vs 12m ago 3.13% < -2% |
| Gross Margin: 63.95% > 18% (prev 69.66%; Δ -5.72% > 0.5%) |
| Asset Turnover: 29.68% > 50% (prev 32.71%; Δ -3.03% > 0%) |
| Interest Coverage Ratio: 5.26 > 6 (EBIT TTM 26.8b / Interest Expense TTM 5.10b) |
| A: 0.03 (Total Current Assets 55.6b - Total Current Liabilities 47.5b) / Total Assets 303b |
| B: -0.00 (Retained Earnings -1.11b / Total Assets 303b) |
| C: 0.11 (EBIT TTM 26.8b / Avg Total Assets 242b) |
| D: 0.28 (Book Value of Equity 66.8b / Total Liabilities 236b) |
| Altman-Z'' = 1.21 = BB |
| DSRI: 1.06 (Receivables 11.4b/8.84b, Revenue 71.8b/59.0b) |
| GMI: 1.09 (GM 69.66% / 63.95%) |
| AQI: 0.50 (AQ_t 0.28 / AQ_t-1 0.57) |
| SGI: 1.22 (Revenue 71.8b / 59.0b) |
| TATA: -0.09 (NI 18.9b - CFO 46.9b) / TA 303b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of October 14, 2026, the stock is trading at USD 143.20 with a total of 26,301,920 shares traded. Over the past week, the price has changed by -0.72%, over one month by -0.73%, over three months by +9.27% and over the past year by -52.89%.
Current recommended Stop Loss: 133.20 (which is 7% or 1.6 ATR below the current price).
Oracle has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy ORCL.
- StrongBuy: 27
- Buy: 8
- Hold: 7
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 238 | 66.2% |
P/E Trailing = 22.5025
P/E Forward = 17.762
P/S = 5.7309
P/B = 7.0709
P/EG = 0.8072
Revenue TTM = 71.8b USD
EBIT TTM = 26.8b USD
EBITDA TTM = 37.7b USD
Long Term Debt = 118b USD (from longTermDebt, last quarter)
Short Term Debt = 7.62b USD (from shortTermDebt, last quarter)
Debt = 187b USD (from shortLongTermDebtTotal, last quarter) + Leases 30.6b
Net Debt = 149b USD (calculated: Debt 187b - CCE 37.1b)
Enterprise Value = 561b USD (411b + Debt 187b - CCE 37.1b)
Interest Coverage Ratio = 5.26 (Ebit TTM 26.8b / Interest Expense TTM 5.10b)
EV/FCF = -19.53x (Enterprise Value 561b / FCF TTM -28.7b)
FCF Yield = -5.12% (FCF TTM -28.7b / Enterprise Value 561b)
FCF Margin = -40.01% (FCF TTM -28.7b / Revenue TTM 71.8b)
Net Margin = 26.36% (Net Income TTM 18.9b / Revenue TTM 71.8b)
Gross Margin = 63.95% ((Revenue TTM 71.8b - Cost of Revenue TTM 25.9b) / Revenue TTM)
Gross Margin QoQ = 60.03% (prev 65.18%)
Tobins Q-Ratio = 1.85 (Enterprise Value 561b / Total Assets 303b)
Interest Expense / Debt = 2.74% (Interest Expense 5.10b / Debt 187b)
Taxrate = 12.92% (2.81b / 21.8b)
NOPAT = 23.4b (EBIT 26.8b * (1 - 12.92%))
Current Ratio = 1.17 (Total Current Assets 55.6b / Total Current Liabilities 47.5b)
Debt / Equity = 2.79 (Debt 187b / totalStockholderEquity, last quarter 66.8b)
Debt / EBITDA = 3.96 (Net Debt 149b / EBITDA 37.7b)
Debt / FCF = -5.20 (negative FCF - burning cash) (Net Debt 149b / FCF TTM -28.7b)
Total Stockholder Equity = 44.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.82% (Net Income 18.9b / Total Assets 303b)
RoE = 42.58% (Net Income TTM 18.9b / Total Stockholder Equity 44.4b)
RoCE = 16.55% (EBIT 26.8b / Capital Employed (Equity 44.4b + L.T.Debt 118b))
RoIC = 9.00% (NOPAT 23.4b / Invested Capital 260b)
WACC = 10.44% (E(411b)/V(598b) * Re(14.09%) + D(187b)/V(598b) * Rd(2.74%) * (1-Tc(0.13)))
Discount Rate = 14.09% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.31 | Cagr: 2.56%
[DCF] Fair Price = unknown (Cash Flow -28.7b)
EPS Correlation: 95.66 | EPS CAGR: 13.00% | SUE: 1.12 | # QB: 2
Revenue Correlation: 96.50 | Revenue CAGR: 11.95% | SUE: 1.16 | # QB: 1
EPS current Quarter (2026-11-30): EPS=1.89 | Chg30d=+0.20% | Revisions=+6% | Analysts=33
EPS next Quarter (2027-02-28): EPS=2.02 | Chg30d=-2.05% | Revisions=-58% | Analysts=32
EPS current Year (2027-05-31): EPS=8.14 | Chg30d=+0.96% | Revisions=+87% | GrowthEPS=+6.7% | GrowthRev=+34.2%
EPS next Year (2028-05-31): EPS=11.00 | Chg30d=+0.29% | Revisions=+36% | GrowthEPS=+35.1% | GrowthRev=+45.7%
[Analyst] Revisions Ratio: +24% (up=78, down=47)